Task: Answer the following question about the molecule with SMILES Nc1nccc(-c2ccc(O)c(-c3ccnc(N)n3)n2)n1.
Description: Please describe this drug.
Answer: Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Nc1nccc(-c2ccc(O)c(-c3ccnc(N)n3)n2)n1
C1=CC(=NC(=C1O)C2=NC(=NC=C2)N)C3=NC(=NC=C3)N
2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol
Please describe this drug.
Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).